20 November 2020
Issue 29 | By Matt Fletcher, Dan Ryan, John Roberts
In this issue we touch on:
– Vaccine breaking news
BioNTech / Pfizer
Moderna
AstraZeneca / University of Oxford
– COVID-19 attacking brain astrocytes
– News on Tocilizumab from the REMAP-CAP trial
– Personalised risk prediction from Medicare
– Benefits of universal mask use
– COVID-19 at the cellular level
– Imperial College Reports
How can we keep schools and universities open?
Modelling ICU capacity under different epidemiological scenarios
– London school of Hygiene and Tropical Medicine
Assessment of tiered restrictions and a second lockdown
– Demographic and Occupational Influences in Hospital Staff
– ONS Infectivity Update
– R Estimate